Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: Results of a German multicenter study [1]

Journal of Investigative Dermatology

Volumn 114, Issue 2, 2000, Pages 395-396

  Bosserhoff, Anja Katrin ^a,b   Hauschild, Axel ^a,b   Hein, Rüdiger ^c   Schadendorf, Dirk ^c   Stockfleth, Eggert ^a,b   Bogenrieder, Thomas ^d   Landthaler, Michael ^d   Buettner, Reinhard ^d   Stolz, Wilhelm ^d  

^a UNIVERSITY OF KIEL   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Clinical Cooperation Unit for Dermatology (DKFZ)   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER IMMUNOTHERAPY; CANCER STAGING; CHROMOSOME 19Q; CONTROLLED STUDY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA INHIBITORY ACTIVITY; METASTASIS; PRIORITY JOURNAL;

EID: 0034053639     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00889.x     Document Type: Letter

References (5)

1. A. Blesch A.K. Bosserhoff R. Apfel Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA Cancer Res 54 1994 5695 5701
2. A.K. Bosserhoff M. Kaufmann B. Kaluza MIA, a novel serum marker for progression of malignant melanoma Cancer Res 57 1997 3149 3153
3. D. Dréau A.K. Bosserhoff R.L. White R. Buettner W.D. Holder Melanoma-inhibitory activity protein, a useful marker to monitor melanoma patients treated with immunotherapy Oncol Res 11 1999 55 61
4. M.R. Koehler A.K. Bosserhoff G. von Beust Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.4 by fluorescence in situ hybridization (FISH) Genomics 35 1996 265 267 10.1006/geno.1996.0352
5. G. Miliotes G.H. Lyman C.W. Cruse Evaluation of new putative tumor markers for melanoma Ann Surg Oncol 3 1996 558 563